CRLBF — Cresco Labs Inc.
—
OTC ·
Materials ·
Chemicals ·
CIK 1832928 ·
Last close
$0.78
Market Cap
$277.36M
52W High
$0.98
52W Low
$0.59
ADV30
390,967
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 173,341,000 | 86,947,000 | 13,361,000 | 16,796,000 | 1,263,320,000 | 32,872,000 | 999,970,000 |
| Mar 2026 | 151,325,000 | 75,449,000 | 11,173,000 | -13,072,000 | 1,198,859,000 | 32,345,000 | 954,648,000 |
| Dec 2025 | 161,553,000 | 83,321,000 | 17,755,000 | -87,588,000 | 1,197,300,000 | 57,902,000 | 944,798,000 |
| Sep 2025 | 164,913,000 | 79,360,000 | 20,193,000 | -17,054,000 | 1,280,338,000 | 45,413,000 | 940,167,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$36,796,000
Investing CF
$-47,067,000
Financing CF
$-85,001,000
CapEx
$-41,069,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.18
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,498,977,000
Inventory
$111,172,000
Receivables
$39,884,000
ST Investments
—
EBIT TTM
$-41,898,000
Pretax Income TTM
$-103,638,000
Interest Exp TTM
$61,740,000
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$651,132,032
EBITDA
$111,141,000
Free Cash Flow
$24,946,750
Enterprise Value
$754,232,768
Total Cash
$32,872,000
Total Debt
$592,017,984
Shares Out
355,588,670
Trailing EPS
$-0.28
Book Value
$0.96
ROE
-36.1%
ROA
3.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 655,847,000 | 76,944,000 | -135,408,000 | 1,197,300,000 | 944,798,000 | — | 72,890,000 |
| Dec 2024 | 724,343,000 | 109,282,000 | -74,438,000 | 1,355,355,000 | 967,179,000 | — | 132,480,000 |
| Dec 2023 | 770,885,000 | 62,880,000 | -175,522,000 | 1,358,467,000 | 930,400,000 | — | 58,564,000 |
| Dec 2022 | 842,681,000 | 56,932,000 | -212,047,000 | 1,583,692,000 | 996,009,000 | — | 18,741,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.04
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LODE | Comstock Inc. | $267.97M | $3.53 | — |
| LTBR | LIGHTBRIDGE Corp | $291.05M | $7.77 | — |
| NAGE | Niagen Bioscience, Inc. | $255.66M | $3.21 | — |
| USNA | USANA HEALTH SCIENCES INC | $250.91M | $13.58 | — |
| ACB | AURORA CANNABIS INC | $249.44M | $3.94 | — |
News headlines (Yahoo Finance, 1h cache)
Cresco Labs Inc. (CRLBF) Q2 Earnings and Revenues Top Estimates
2026-08-06 13:50 · Yahoo
Cresco Labs Reports Second Quarter 2026 Financial Results; Delivers $173 Million in Revenue and $40 Million in Adjusted EBITDA
2026-08-06 10:30 · Yahoo
Cresco Labs to Report Second Quarter 2026 Financial Results on August 6, 2026
2026-07-13 10:30 · Yahoo
GTBIF Stock Climbs 17.5% in Three Months: Time to Invest or Cash Out?
2026-06-18 12:28 · Yahoo
Cannabis Operator Cresco Down 28.5% YTD: How to Play the Stock?
2026-06-11 12:12 · Yahoo
Cresco Labs Closes US$50 Million Revolving Credit Facility with Needham Bank
2026-06-08 10:00 · Yahoo
Cresco Labs Inc. (CRLBF) Upgraded to Buy: Here's Why
2026-05-11 16:00 · Yahoo
Cresco Labs Inc. (CRLBF) Reports Q1 Loss, Beats Revenue Estimates
2026-05-08 12:05 · Yahoo
Maravai LifeSciences Holdings, Inc. (MRVI) Tops Q1 Earnings and Revenue Estimates
2026-05-07 21:55 · Yahoo
Why Fast-paced Mover Cresco Labs Inc. (CRLBF) Is a Great Choice for Value Investors
2026-05-06 12:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.